125 related articles for article (PubMed ID: 8270182)
1. Beta-endorphin levels in women with elevated prolactin and following bromocriptine therapy.
Lox CD; Pau KY
Gen Pharmacol; 1993 Sep; 24(5):1231-3. PubMed ID: 8270182
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
Smith S
J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
[TBL] [Abstract][Full Text] [Related]
3. Different effects of fenofibrate on cardiometabolic risk factors in young women with and without hyperprolactinemia.
Krysiak R; Szkróbka W; Okopień B
Pharmacol Rep; 2019 Feb; 71(1):61-66. PubMed ID: 30469130
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine is unable to suppress TRH-stimulated beta-endorphin/beta-lipotropin and cortisol secretion in normal pregnant women after delivery.
Lamberts SW; Angement R; van der Heijden A; Wladimiroff JW; Hackeng WH; de Jong FH
Horm Res; 1987; 27(4):195-9. PubMed ID: 2963790
[TBL] [Abstract][Full Text] [Related]
5. Alternative Treatment Strategies in Women Poorly Tolerating Moderate Doses of Bromocriptine.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):360-364. PubMed ID: 28073129
[No Abstract] [Full Text] [Related]
6. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Sabuncu T; Arikan E; Tasan E; Hatemi H
Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944
[TBL] [Abstract][Full Text] [Related]
7. The effect of bromocriptine treatment on sexual functioning and depressive symptoms in women with mild hyperprolactinemia.
Krysiak R; Szkróbka W; Okopień B
Pharmacol Rep; 2018 Apr; 70(2):227-232. PubMed ID: 29475005
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinemia with prolonged amenorrhea reversed with bromocriptine in a menopausal woman.
Goldman M; Steinberger A; Ganti S
Am J Obstet Gynecol; 1988 Jan; 158(1):117-8. PubMed ID: 3122579
[TBL] [Abstract][Full Text] [Related]
9. Vaginal bromocriptine--clinical and biochemical effects.
Ginsburg J; Hardiman P; Thomas M
Gynecol Endocrinol; 1992 Jun; 6(2):119-26. PubMed ID: 1502929
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia.
Kletzky OA; Vermesh M
Fertil Steril; 1989 Feb; 51(2):269-72. PubMed ID: 2912773
[TBL] [Abstract][Full Text] [Related]
11. [The results of using parlodel in hyperprolactinemia].
Mel'nichenko GA; Gitel' EP; Romantsova TI
Probl Endokrinol (Mosk); 1990; 36(3):29-33. PubMed ID: 2395828
[TBL] [Abstract][Full Text] [Related]
12. Prolactin (PRL) response to oral or vaginal bromoergocriptine in hyperprolactinemic women.
Dash RJ; Ajmani AK; Sialy R
Horm Metab Res; 1994 Mar; 26(3):164. PubMed ID: 8005568
[No Abstract] [Full Text] [Related]
13. Regulation of the photoperiod-induced cycle in the peripheral blood concentrations of beta-endorphin and prolactin in the ram: role of dopamine and endogenous opioids.
Ssewannyana E; Lincoln GA
J Endocrinol; 1990 Dec; 127(3):461-9. PubMed ID: 2280212
[TBL] [Abstract][Full Text] [Related]
14. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
Schiebinger RJ; Chrousos GP; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 Jan; 62(1):202-9. PubMed ID: 2999177
[TBL] [Abstract][Full Text] [Related]
15. Effect of bromocriptine on affect and libido in hyperprolactinemia.
Koppelman MC; Parry BL; Hamilton JA; Alagna SW; Loriaux DL
Am J Psychiatry; 1987 Aug; 144(8):1037-41. PubMed ID: 3300375
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
Yuen BH
Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
[TBL] [Abstract][Full Text] [Related]
17. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
Prathibha D; Govardhani M; Krishna PT
J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
[TBL] [Abstract][Full Text] [Related]
18. Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
Krysiak R; Okopien B
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):251-6. PubMed ID: 25123447
[TBL] [Abstract][Full Text] [Related]
19. Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.
Tørring O; Isberg B; Sjöberg HE; Bucht E; Hulting AL
Acta Endocrinol (Copenh); 1993 May; 128(5):423-7. PubMed ID: 8317189
[TBL] [Abstract][Full Text] [Related]
20. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
